Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Common variable immunodeficiency (CVID) associated liver disease is an underrecognized and poorly studied non-infectious complication that lacks an established treatment. We describe a CVID patient with severe multiorgan complications, including non-cirrhotic portal hypertension secondary to nodular regenerative hyperplasia leading to diuretic-refractory ascites. Remarkably, treatment with rituximab, administered for concomitant immune thrombocytopenia, resulted in the complete and sustained resolution of portal hypertension and ascites. Our case, complemented with a literature review, suggests a beneficial effect of rituximab that warrants further research.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546204PMC
http://dx.doi.org/10.3389/fimmu.2023.1264482DOI Listing

Publication Analysis

Top Keywords

nodular regenerative
8
liver disease
8
common variable
8
variable immunodeficiency
8
portal hypertension
8
rituximab improved
4
improved nodular
4
regenerative hyperplasia-associated
4
hyperplasia-associated non-cirrhotic
4
non-cirrhotic liver
4

Similar Publications

Cardiopulmonary changes and its association with clinical features in noncirrhotic portal hypertension.

World J Gastroenterol

August 2025

Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, United States.

Background: Cardiopulmonary changes in noncirrhotic portal hypertension (NCPH) are poorly understood.

Aim: To investigate cardiopulmonary changes using transthoracic echocardiography (TTE) in NCPH and their correlation with clinical features.

Methods: Prospective cohort including 10 preclinical NCPH [without portal hypertension (PH)] and 32 NCPH subjects who underwent TTE with agitated saline injection and comprehensive clinical evaluation were assessed.

View Article and Find Full Text PDF

Objective: The number of orthotopic heart transplants (OHTs) performed each year continues to increase, as does the post-transplant survival rate. Little is known, however, about the morphologic changes in the liver after the patient has undergone an OHT. In this study, we retrospectively reviewed liver pathology in patients following OHT to comprehensively describe the histopathologic changes, particularly fibrosis.

View Article and Find Full Text PDF

Hepatobiliary (HB)-specific magnetic resonance imaging (MRI) contrast agents, particularly gadoxetic acid, are being increasingly utilized for liver imaging, with well-established clinical utility. The most distinctive feature of gadoxetic acid is HB phase imaging performed 20 min after administration. In clinical practice, most focal liver lesions lack gadoxetic acid uptake and appear hypointense against the background of normally enhancing liver parenchyma owing to the absence of hepatocyte function within the tumor tissue.

View Article and Find Full Text PDF

Noncirrhotic Portal Hypertension: Current Concepts and Overview of Causes, Pathophysiology, and Imaging Findings.

Radiographics

September 2025

From the Department of Radiology and Surgery, Division of Body Imaging (A.A.B., M.H., R.C., F.H.M.), Department of Medicine, Division of Gastroenterology and Hepatology (J.R.B.), and Department of Radiology, Division of Interventional Radiology (B.T.), Northwestern University Feinberg School of Medi

Noncirrhotic portal hypertension (NCPH) is an uncommon but important entity caused by impaired flow dynamics in the portal venous system in the absence of advanced fibrosis. The exact prevalence of this disease is unknown since many patients with NCPH are labeled as having cryptogenic cirrhosis. Numerous disease processes performed with different mechanisms can result in this entity.

View Article and Find Full Text PDF

Objectives: Patients with extremity sarcomas may require amputation when limb salvage surgery is not possible. Targeted muscle reinnervation (TMR) and regenerative peripheral nerve interface (RPNI) are procedures that can reduce neuroma formation, though neuromas can still occur. This study aims to describe the MRI characteristics of TMR/RPNI, examine changes in neuromas over time, and differentiate these from sarcoma recurrence on MRI.

View Article and Find Full Text PDF